IMU: Is it all too late?, page-37

Mate, sorry about your pain, I know, I've been there with SGH. This from IMU's own fact sheet, so anything positive is years away if at all, any money put in to IMU should be speccy money you can afford to lose, all in my opinion only of course and we know what Slick thinks of that haha.

"HER-VAXX PHASE 1B/2 CLINICAL TRIAL
• Gastric Cancer Study to start recruitment in 2H2017
• Open label, randomized 1:1, Phase 1b/2 trial in ~86 patients
• Patients with metastatic gastric cancer overexpressing HER2
• HER2/neu Peptide Vaccine Plus Cisplatin and either 5-Fluorouracil or
Capecitabine Chemotherapy
• Cost approximately $8.5m AUD, conducted mainly in Asia
• First patient in 2H2017 – last patient out 2H2019"​